# Ultrasonic Enhancement Delivery of Phosphodiesterase Inhibitors Nanoparticles for Diabetic Management of the Foot

> **NCT07690566** · NA · COMPLETED · sponsor: **Deraya University** · enrollment: 1 (actual)

## Conditions studied

- Diabetic Foot
- Wound Healing Delayed
- Diabete Mellitus
- Amputation

## Interventions

- **DRUG:** Tadalafil

## Key facts

- **NCT ID:** NCT07690566
- **Lead sponsor:** Deraya University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-20
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2026-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07690566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07690566, "Ultrasonic Enhancement Delivery of Phosphodiesterase Inhibitors Nanoparticles for Diabetic Management of the Foot". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07690566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*